← Back to Search

Palliative Care Intervention for Bone Marrow Transplant

N/A
Waitlist Available
Led By Areej El-Jawahri, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient Inclusion Criteria
adult patients (≥ 18 years) with hematologic malignancy admitted for autologous or allogeneic HCT.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights

Study Summary

This trial is testing whether getting palliative care early on will improve quality of life, symptoms, and mood for people going through stem cell transplantation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
Requirements for being included in the study.
Select...
You are an adult (18 years or older) with a type of blood cancer and are being treated with a bone marrow or stem cell transplant.
Select...
You must be able to understand and answer questions in either English or Spanish. If needed, you can have an interpreter to help you answer questions.
Select...
You have a friend or family member who is 18 years or older and is willing to participate in the study with you. The person must have regular in-person contact with you at least twice a week and must be someone you have identified.
Select...
You must be able to read and understand questions in either English or Spanish, or be able to complete questionnaires with the help of an interpreter.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient-reported Quality of Life (QOL): Functional Assessment of Cancer Therapy - Bone Marrow Transplant (FACT-BMT)
Secondary outcome measures
Caregiver Depression
Caregiver Psychological Distress
Caregiver QOL: CARGOQOL
+6 more
Other outcome measures
Caregiver Coping
Mediation Analysis (Symptom Burden and Coping) as Mediators of Improvement in Patient-reported QOL
Moderation Analysis to Examine Whether Patient or Transplant Related Characteristics Are Moderators of the Effect of the Intervention on Patient-reported QOL
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Transplant Care AloneExperimental Treatment1 Intervention
Patients and Caregivers will complete baseline self-report assessments at the time of obtaining informed consent. Standard Transplant Care
Group II: Inpatient Palliative Care InterventionExperimental Treatment1 Intervention
Patients and Caregivers will complete baseline self-report assessments at the time of obtaining informed consent Palliative Care Intervention Therapeutic Relationship --Develop a strong therapeutic relationship with patients and caregivers Assessment and Treatment of Patient Symptoms --Clarify the symptoms the patient will likely experience and offer reassurance about the methods for reporting and treating symptoms Managing Patients and Caregivers Expectations --Address early on patients and caregivers' concerns about the trajectory of illness during HCT and treatment side effects Coping with Illness and HCT --Introduce strategies to help improve adjustment (e.g., behavioral, cognitive, and spiritual approaches; accepting illness while maintaining hope; social support)

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,918 Previous Clinical Trials
13,192,289 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,679 Previous Clinical Trials
6,910,136 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,609 Previous Clinical Trials
40,915,100 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment efforts underway for this research endeavor?

"According to clinicaltrials.gov, the trial recruitment process for this study has now concluded - it was initially posted on September 30th 2018 and last updated August 23rd 2022. Despite not being able to join this particular experiment, there are 46 other trials actively seeking participants."

Answered by AI
~85 spots leftby Mar 2025